![Johnson and Johnson](/common/images/company/NY_JNJ.png)
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division ... Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. Show more
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held at the New York Marriott Marquis, New York, NY...
Beasley Allen, Levin Papantonio, and coalition of law firms cite misleading efforts to secure approval Thousands of individuals who are being told they may be eligible for quick and significant...
Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with treatment-resistant depression PR Newswire TITUSVILLE, N.J., July 22...
U.S. index futures are registering a significant drop in pre-market trading this Wednesday, with the technology sector being the most affected. At 5:50 AM, Dow Jones futures (DOWI:DJI) fell 78...
Spirit Airlines (NYSE:SAVE) – Spirit Airlines reduced its revenue forecast for the second quarter to $1.28 billion, down from the previous estimate of $1.32-1.34 billion, due to lower...
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2024 of $1.24 per share on the company’s common stock. The...
2024 Second-Quarter reported sales growth of 4.3% to $22.4 Billion with operational growth of 6.6%* and adjusted operational growth of 6.5%*. Adjusted operational growth excluding COVID-19...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.45 | 2.85989717224 | 155.6 | 160.58 | 151.57 | 6710893 | 154.77973943 | CS |
4 | 13.22 | 9.00360961656 | 146.83 | 160.58 | 144.5 | 6504807 | 150.52925121 | CS |
12 | 8.28 | 5.45562364104 | 151.77 | 160.58 | 143.71 | 7012049 | 149.01722692 | CS |
26 | 1.05 | 0.660377358491 | 159 | 163.11 | 143.13 | 7355157 | 152.39791866 | CS |
52 | -10.4 | -6.10149603989 | 170.45 | 175.97 | 143.13 | 11024267 | 160.63616034 | CS |
156 | -11.86 | -6.89895875749 | 171.91 | 186.69 | 143.13 | 8480238 | 164.7562932 | CS |
260 | 29.99 | 23.0585883438 | 130.06 | 186.69 | 109.16 | 8159729 | 158.01625733 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.